The Federal Competition and Consumer Protection Commission
(FCCPC), says it will work with relevant authorities to prevent entry or sale of
substandard cough syrups in the country’s market.

A statement issued by Mr Babatunde Irukera, the Executive Vice Chairman of
FCCPC in Abuja today, advised stakeholders to comply strictly with NAFDAC’s
protocols identified in the agency’s Regulations and Guidelines.

Irukera said that the National Agency For Food And Drug Administration And
Control (NAFDAC) had issued a warning to importers, distributors, retailers,
and consumers to refrain from the importation, distribution, sale and use of
four cough syrups.

He said the cough syrups were made by Maiden Pharmaceuticals and
manufactured in India. The products include Promethazine Oral Solution,
Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold
Syrup.